Showing results (91-100 of 336) with videos related to
Sort By:
Pageof 34
World Journal of Urology|November 7, 1999
Future prospects in the chemotherapy of metastatic nonseminomatous testicular germ-cell cancerJ T Hartmann, M A Kuczyk, C Kollmannsberger, et al.Oncology Reports|May 20, 2011
Malignant fibrous histiocytoma of bone - Review of thirteen casesJ Hartmann, I Thiel, H Schmoll, et al.Oncology Reports|May 21, 2011
Antitumor-activity and toxicity of continuous-infusion versus bolus administration of bleomycin in 2 heterotransplanted human testicular cancer cell-linesC Bokemeyer, E Ludwig, D Reile, et al.Oncology|January 1, 1996
Evaluation of late nephrotoxicity in long-term survivors of Hodgkin's diseaseL M Fels, C Bokemeyer, J van Rhee, et al.International Journal of Cancer|February 1, 1994
Modulation of cytostatic drugs by nifedipine in two heterotransplanted human testicular-cancer cell lines differing in their sensitivity to standard agentsC Bokemeyer, T Dunn, A Harstrick, et al.Medizinische Klinik (Munich, Germany : 1983)|April 15, 1997
[Clinical value of the CA 19-9 tumor marker with special reference to the Lewis phenotype]G Kolb, F Safi, K Beckh, et al.Mediators of Inflammation|January 1, 1992
Stimulation of neutrophil functions by C5a(desArg): an in vitro model of haemodialysisI Eckle, G Kolb, E M Martin, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|March 1, 1997
Diagnostic value of CA 19-9 in patients with pancreatic cancer and nonspecific gastrointestinal symptomsF Safi, W Schlosser, G Kolb, et al.Seminars in Surgical Oncology|December 10, 1999
Late toxicity following curative treatment of testicular cancerC Kollmannsberger, M Kuzcyk, F Mayer, et al.Journal of Cancer Research and Clinical Oncology|January 1, 1994
Preliminary results of a phase I/II trial of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancerC Bokemeyer, H J Schmoll, F Natt, et al.Pageof 34